Apotex Sends Latest Biosimilar Application To FDA
Apotex Inc. on Tuesday announced that the U.S. Food and Drug Administration has accepted its application for a copycat version of Amgen Inc.'s blockbuster biologic Neupogen, marking the agency's fifth known...To view the full article, register now.
Already a subscriber? Click here to view full article